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Abstract Isotretinoin was formulated in novel mi-
croemulsion-based gel formulation with the aim of im-
proving its solubility, skin tolerability, therapeutic efficacy,
skin-targeting efficiency and patient compliance. Mi-
croemulsion was formulated by the spontaneous mi-
croemulsification method using 8 % isopropyl myristate,
24 % Labrasol, 8 % plurol oleique and 60 % water as an
external phase. All plain and isotretinoin-loaded mi-
croemulsions were clear and showed physicochemical pa-
rameters for the desired topical delivery and stability. The
permeation profiles of isotretinoin through rat skin from
selected microemulsion formulation followed zero-order
kinetics. Microemulsion-based gel was prepared by incor-
porating Carbopol971 in optimized microemulsion for-
mulation having suitable skin permeation rate and skin
uptake. Microemulsion-based gel showed desired physi-
cochemical parameters and demonstrated advantage over
marketed formulation in improving the skin tolerability of
isotretinoin, indicating its potential in improving topical
delivery of isotretinoin. The developed microemulsion-
based gel may be a potential drug delivery vehicle for
targeted topical delivery of isotretinoin in the treatment of
acne.
Keywords Acne  Isotretinoin  Microemulsion  Skin
irritation study  Skin retention study  Topical drug
delivery
Introduction
Acne, a cutaneous disorder of multifactorial origin, is a
disease whose cause and severity depend on the relation-
ship between hormones, keratinization, sebum and bacte-
ria. The objectives of acne therapy usually include
controlling acne lesions, preventing scarring and
minimizing morbidity (Russell 2000; Zaenglein 2008).
Isotretinoin (ITTN), a derivative of retinoic acid (13-cis-
retinoic acid), is the most effective compound with po-
tential to suppress acne over the long term (Zaenglein
2008; Patel et al. 2011a). It appears to derive its effec-
tiveness from increased production of the antimicrobial
protein neutrophil gelatinase-associated lipocalin in the
skin reducing sebum levels and in turn reducing levels of
Propionibacterium acnes (P. acnes). An ongoing trial in
patients with antibiotic-resistant P. acnes indicates that
ITTN is highly effective; treatment of P. acnes may well
become a new indication for this drug (Zaenglein 2008).
So, ITTN, reducing the growth of P.acnes in a secondary
manner, was selected for further study. However despite
these interesting features, extremely low solubility limits
ITTN incorporation into an acceptable vehicle and its tol-
erability results in either discontinuation of treatment or
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poor compliance in patients (Zaenglein 2008; Patel et al.
2011a). Therefore, it is prudent to improve the topical
delivery and reduce adverse effects of ITTN using an ap-
propriate carrier having the desired skin-targeting proper-
ties that may reduce the adverse reactions substantially and
improve users’ compliance to the novel regimen.
The conventional anti-acne formulations could be less
efficacious due to insignificant skin penetration properties.
In comparison, the novel drug delivery systems of recently
available anti-acne formulations have potential to reduce
the adverse effects without reducing the efficacy. Mi-
croemulsion (ME) offers a powerful way for drug delivery
as colloidal drug carrier, due to its versatility and favorable
advantages (Bachhav and Patravale 2009; Djordjevic 2004;
Patel et al. 2009, 2011b, 2013a, b, c). The application of
ME systems to skin distributes the anti-acne
agent(s) steadily and reduce irritation. These systems have
also been shown to promote follicular targeting and thus
create high local concentrations of the active compound in
the pilosebaceous unit and efficient penetration in hair
follicles (Zaenglein 2008; Patel et al. 2011a). Thus, MEs
could play a pivotal role in improving topical delivery of
anti-acne agents by enhancing their dermal localization
with concomitant reduction in their adverse effects. ME-
based gels (MBG) are known to provide faster drug release
than conventional formulations (Bachhav and Patravale
2009). A ME-based gel was thus developed and evaluated
using a suitable polymer that is capable of modifying the
rheological behavior.
To find out innovative ways for administering ITTN and
assuaging their disadvantages, the present study investi-
gated the development of ME-based gel containing ITTN.
It was hypothesized that the oily core present around ITTN
may result in the reduction of irritation when presented in
the form of ME. The combination of effects, viz. equal and/
or enhanced effectiveness, reduction in adverse reactions
and regimen adherence may provide a better platform of
novel drug delivery with improved therapeutic efficacy.
Thus, the present study focuses on novel formulation
consideration, characterization and evaluation of skin-tar-
geting efficiency of ITTN when loaded with MBG.
Materials and methods
Materials
ITTN was procured as gratis samples from Astron Re-
search Ltd. (Ahmedabad, India). Labrasol, plurol oleique
(Gattefosse, Saint-Priest, France), Carbopol 980 NF, Car-
bopol 971P NF, Carbopol 974P NF, (Lubrizol Advanced
Materials India Pvt. Ltd., Mumbai, India), Methocel E50
LV premium hydroxypropyl methylcellulose EP grade and
Methocel KM premium hydroxypropyl methylcellulose
(Colorcon Asia Pvt. Ltd., Goa, India) were procured on
gratis. Isopropyl myristate was purchased from National
Chemicals (Vadodara, India). Ethanol was purchased from
Baroda Chemical Ind. Ltd. (Dabhoi, India). Double dis-
tilled water was used throughout the study. All other che-
micals and solvents were of analytical reagent grade and
were used as received without further purification.
Methods
Solubility determination
The solubility of ITTN was determined in various oils,
emulsifiers, and co-emulsifiers. In this experiment, excess
amount of ITTN was added in 1 mL of each excipient and
mixed thoroughly using vortexer at ambient temperature
(Patel et al. 2009). The mixed samples were kept for 72 h
to allow equilibration. Then the samples were centrifuged
at 50009g for 30 min to separate the undissolved drug.
Supernatants were diluted and analyzed by the HPTLC
method (Patel et al. 2011a) to estimate the concentration of
soluble ITTN. Excipients in which ITTN showed good or
excellent solubility were chosen for preparing MEs.
Construction of phase diagrams
The pseudo-ternary phase diagrams were constructed using
water titration method at ambient temperature. Three phase
diagrams were constructed with the 1:1, 2:1 and 3:1 weight
ratios of emulsifier/co-emulsifier mixture (Emix) of
Labrasol (LAB) and plurol oleique (PO), respectively. For
each phase diagram at a specific emulsifier/co-emulsifier
mixing ratio (Km), the ratio of isopropyl myristate (IPM) to
the Emix was varied as 1:9, 2:8, 3:7, 4:6, 5:5, 6:4, 7:3, 8:2
and 9:1. Spontaneous formation of ME was evaluated by
the addition of a known amount of water at once to a
known amount of oil, emulsifier and co-emulsifier with
controlled stirring. The ease of formation of clear ME was
taken as the criteria of spontaneity of microemulsification
(Patel et al. 2009, 2011b, 2013a, b, c).
Preparation of microemulsions
Six potential ME formulations, which were different from
each other by water volume fraction, were selected and
formulated at Km 3:1 by the spontaneous microemulsifi-
cation method. A calculated amount of ITTN (0.05 % w/
w) was added to the oily phase of ME and magnetically
stirred until dissolved, followed by addition of Emix in a
fixed proportion to produce a clear mixture. Then, a defined
proportion of water was added and stirred to produce clear
ME containing ITTN (Patel et al. 2013c).
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Preparation of microemulsion-based gel
Carbopol 971P NF was selected as the gel matrix to
prepare ME-based gel (MBG). It was entirely swollen upon
slow mixing in the water and its pH was adjusted by adding
50 % w/w triethanolamine (TEA). MBG was obtained by
mixing the swollen gel in water with the oily phase
(Bachhav and Patravale 2009; Chen et al. 2007).
Characterization of formulations
The average droplet size and polydispersity index (PDI) of
ME were measured by photon correlation spectroscopy
(PCS) with in-built Zetasizer (Nano ZS, Malvern Instru-
ments, UK) at 633 nm. Helium–neon gas laser having in-
tensity of 4mW was the light source. The droplet size was
calculated using Stokes–Einstein relationship by Zetasizer
Software. Electrophoretic mobility (lm/s) was measured
using small volume disposable zeta cell and converted to
zeta potential by in-built software using Helmholtz–S-
moluchowski equation. All determinations were made in
triplicate. TEM was used to characterize the microstructure
of ITTN-loaded ME. The TEM images were obtained using
a Tecnai G2 20 TEM (Philips, Holland). ITTN content in
the formulation was assayed using an HPTLC (Patel et al.
2011a). The percent transmittance of the formulation was
measured using a colorimeter (Digital Colorimeter, D-801,
Photocon, India) at 570–590 nm. The isotropic nature of
the ME formulations was verified using cross-polarized
light microscopy (Polarizing Microscope RPL-55 Series,
Radical Instruments, India). The pH value of the formu-
lation was determined using a digital pH meter (HI 98107,
Hanna Instruments, India) which was standardized using
pH 4 and 7 buffers before use. The electric conductivity of
ME was measured using a conductivity meter (Equip-
Tronics, EQ—664, Mumbai, India) equipped with an in-
built magnetic stirrer. The viscosity of ME was measured
using a Brookfield Viscometer LVDV-IIIU (Brookfield
Engineering LABS, Stoughton, USA) with spindle SC 18
at 100 rpm using an interval of 30 s. A rheological study of
the MBG was performed using a viscometer with Helipath
stand (Patel et al. 2009, 2011b, 2013a, b, c).
Determination of spreadability of microemulsion-based gel
The spreadability of the gel was determined by placing
0.5 g gel within a pre-marked circle of 1 cm diameter on a
glass plate over which a second glass plate was placed. A
weight of 500 g was allowed to rest on the upper glass
plate for 5 min. The increase in the diameter due to
spreading of the gels was noted and the mean diameter was
taken by repeating the experiment three times (Bachhav
and Patravale 2009).
In vitro skin permeation study
The in vitro skin permeation study was carried out under
the guidelines proposed by the Committee for the Purpose
of Control and Supervision of Experiments on Animals
(CPCSEA) and all the study protocols were approved by
the Local Institutional Animal Ethics Committee (IAEC).
The abdominal skins obtained from male Wistar rats
weighing 230 ± 20 g (age, 6–8 weeks) were used for
in vitro permeation experiments of the prepared formula-
tions. After hair was shaved carefully with an electric
clipper, the skin was excised from the abdominal region of
each killed rat and the subcutaneous fat and other extra-
neous tissues were removed without damaging the epi-
dermal surface. The excised rat skins were rinsed with
physiological saline and the thickness of each skin tissue
was kept almost similar (Patel et al. 2009, 2011b).
The excised skins were then placed in a refrigerator at
4 C and then used for permeation experiments. The skin
membranes were first hydrated for 30 min in buffer solu-
tion (pH 7.4) at room temperature to remove extraneous
debris and leachable enzymes. The permeation experiments
were performed using Franz diffusion cells fitted with ex-
cised rat skins, such that the dermal side of the skin was
exposed to the receptor fluid and the stratum corneum re-
mained in contact with the donor compartment. The ef-
fective permeation area was 3.14 cm2 (20 mm-diameter
orifice), and the receptor compartment was filled with
12 mL of physiological saline:ethanol (7:3 v/v) for ensur-
ing pseudo-sink conditions by increasing the solubility of
ITTN in the receiving phase. The temperature of the re-
ceiver chamber containing 12 mL of receptor media was
controlled at 32 ± 1 C using circulating equibath (Model
8506, Medica Instrument Mfg. CO, Mumbai, India). The
diffusion medium was continuously stirred with a Teflon-
coated magnetic bar at a constant rate, in a way that the rat
skin surface just flushed the diffusion fluid. The formula-
tion (1 g) was gently placed in a donor chamber and then
the diffusion cells were covered with an aluminum foil to
prevent light exposure. At 1, 2, 4, 6, 8, 10 and 12 h, ali-
quots of 1 mL sample were withdrawn from the receptor
compartment and replaced immediately with an equivalent
volume of receptor fluid. The concentration of ITTN in
receptor fluid was analyzed using the HPTLC method
(Patel et al. 2011a). Each experiment was performed in
triplicate. Cumulative corrections were made to obtain the
total amount of ITTN permeated at each time interval.
The permeation rate was determined using the equation,
Jss = 1/A(dQ/dt)ss = C0Kp, where Jss is the permeation
rate at steady state (lg/cm2/h), A the effective diffusion
area (cm2), (dQ/dt)ss the amount of drug that permeated
through the skin per unit time at steady state (lg/h), C0 the
applied drug concentration in the donor compartment (lg/
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mL) and Kp the permeability coefficient (cm/h). The av-
erage cumulative amount of drug that permeated per unit
surface area of the skin was plotted versus time. The per-
meation rate of ITTN at steady state (Jss, lg/cm
2/h)
through rat skin was calculated from the slope of the linear
portion of the cumulative amount that permeated through
the rat skins per unit area versus time plot. To obtain the
permeability coefficient Kp (cm/h), the following equation
was used: Kp = Jss/C0 (Patel et al. 2009, 2011b).
Stability studies
The stability of ME formulations was studied through
various parameters such as clarity, phase separation ob-
servation, droplet size determinations, viscosity measure-
ments, conductivity measurements, pH and zeta potential
determinations for 6 months at room temperature. To
estimate metastable systems, the selected ME vehicles
were centrifuged (Remi Lab, Mumbai) at 50009g for
30 min. Besides the physicochemical properties, the che-
mical stability of the investigated drug in the vehicle
plays a major role. Therefore, the drug content was ana-
lyzed at defined time intervals during the observation
period of 6 months. During the observation period, the
formulations were stored at room temperature in tubes to
simulate patient usage conditions. During stability studies,
the samples were taken at fixed time intervals (Patel et al.
2011b).
Infrared study
The infrared (IR) spectra of ITTN, unloaded ME, opti-
mized ITTN-ME and ITTN-MBG were taken using an IR
spectrophotometer (Spectrum GX FT-IR, Perkin Elmer,
Norwalk, CT). The unloaded ME, ITTN-ME and ITTN-
MBG were spread as a thin layer on potassium bromide
cell and then scanned between 4000 and 400 cm-1. The
resulting IR spectra of ITTN and plain ME were then
compared with ITTN-ME and ITTN-MBG to detect any
possible interaction between the drug and different com-
ponents used (Patel et al. 2013c).
Skin retention study
Skin retention study was performed to analyze the content
of the drug in the skin. At the end of the in vitro skin
permeation study, the skin samples were washed with
water and methanol on both sides and carefully dried. Then
a defined amount of methanol was added to each piece of
skin. The samples were vortexed for 10 min to extract its
drug content and stirred overnight. The samples were
analyzed by HPTLC (Patel et al. 2011a) after centrifuga-
tion (Bachhav and Patravale 2009).
Histopathological investigation
The rat abdominal skin was mounted on Franz diffusion
cell. The optimized ME, MBG (1 g) and marketed gel were
applied similar to method for permeation study and the
effects were compared against control. A piece of fresh
excised untreated skin sample was used as control. The
skin was fixed in 10 % neutral formalin for 24 h and then
cut vertically against the surface at the central region
(4 mm width). Each section was dehydrated using graded
solutions of ethanol and then embedded in paraffin wax.
Tissues were divided into small pieces and stained with
hematoxylin and eosin. The sections were observed under
1009 magnifications and photographed (Patel et al. 2009,
2011b, 2013a, b, c).
Skin irritation testing (Draize patch test)
The irritation potential of the ME-based ITTN gel in
comparison to marketed ITTN gel was evaluated by car-
rying out the Draize patch test on rabbits. Animal care and
handling throughout the experimental procedure were
performed in accordance with the CPCSEA guidelines.
White New Zealand rabbits weighing 2.5–3 kg were ac-
climatized before the beginning of the study.
Animals were divided into four groups (n = 3) as
follows:
Group 1: no application (control).
Group 2: marketed formulation (Sotret gel containing
0.05 % w/w ITTN, Ranbaxy).
Group 3: MBG without ITTN (placebo gel).
Group 4: MBG containing ITTN (0.05 %, w/w).
The back of the rabbits were clipped free of hair 24 h prior
to the application of the formulations. 0.5 g formulations
were applied on the hair-free skin of rabbits by uniform
spreading within the area of 4 cm2. The skin was observed
for any visible change such as erythema (redness) at 24, 48
and 72 h after the application of various formulations. The
mean erythema scores were recorded (ranging from 0 to 4)
depending on the degree of erythema as follows: no ery-
thema = 0, slight erythema (barely perceptible-light
pink) = 1, moderate erythema (dark pink) = 2, moderate to
severe erythema (light red) = 3 and severe erythema (ex-
treme redness) = 4 (Draize et al. 1944; Shah et al. 2007).
Statistical analysis
All the skin permeation studies were carried out in tripli-
cate and the data were expressed as the mean value ± SD.
Statistical data were analyzed by one-way analysis of
variance (ANOVA). A multiple comparison test was used
to compare different formulations and P\ 0.05 was con-
sidered to be significant.
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Results and discussion
Development and evaluation of microemulsion
The solubility of ITTN in various oils, emulsifiers and co-
emulsifiers was analyzed to screen for components of ME.
The solubility of ITTN was found to be highest in IPM
(42.92 ± 3.97 mg/gm), a low molecular volume fatty acid
ester and one of the most often used oils along with long
chain triglycerides and medium chain triglycerides for ME
(Subramanian et al. 2005). It has been reported that the
large solubilizing capacity of ME leads to larger concen-
tration gradient toward the skin, providing superior dermal
flux, for which high solubility of ITTN in oily phase can be
an added advantage to increase it in ME. Also, literature
reveals that IPM acts as a chemical enhancer by disorder-
ing the prearranged lipids of the horny layer. To study the
influence of oil on ME characteristics and penetration-en-
hancing ability, IPM was chosen for the preparation of ME-
containing ITTN (Patel et al. 2009, 2011b, 2013a, b, c;
Subramanian et al. 2005).
The solubility of ITTN was determined in different
emulsifiers to find a suitable emulsifier for the preparation
of ME. The highest solubility of ITTN was found in LAB
(86.81 ± 4.82 mg/gm) which is a non-ionic emulsifier
used as a pharmaceutical excipient for the solubilization of
hydrophobic drugs. There have been several studies in-
volving low-irritant LAB-based MEs as drug delivery
vehicles for topical application (Alvarez-Figueroa and
Blanco-M´endez 2001; Djekic and Primorac 2008). Also, it
has been reported that LAB-based systems incorporating
fatty acid esters in an oil phase have a large ME region in
their phase diagrams. To facilitate the formulation of LAB-
based MEs, PO has been used as co-emulsifier (Fanun
2008). It has also been reported that solubilization of water
is easier in systems containing LAB as emulsifier and PO
as a co-emulsifier. The highest solubility of ITTN was
found in PO (10.04 ± 3.54 mg/gm) among the co-emul-
sifiers studied. From these results, IPM, LAB and PO were
subsequently used as the oil phase, emulsifier and co-
emulsifier for the formulation of MEs containing ITTN in
this study.
The pseudoternary phase diagrams of the system of
IPM, LAB, PO and water were constructed to find out the
existence range of MEs. The phase diagrams are repre-
sented in Fig. 1. The phase boundary was determined by
observing the changes of the sample appearance from
turbid to transparent or from transparent to turbid based on
visual identification. The isotropic and low-viscosity region
is presented in the phase diagram as the one-phase ME
region (1U) and the remainder of the phase diagram rep-
resents the turbid region, designated as multiphase (MU)
conventional emulsions. From a microstructural point of
view, MEs may sometimes be envisaged as emulsifier ag-
gregrates of water dispersed (solubilized) in oil (w/o) or oil
dispersed in water (o/w). When the ME region extends
Fig. 1 The pseudoternary
phase diagrams of the isopropyl
myristate, Labrasol/plurol
oleique (Emix), water at the 1:1
(X), 2:1 (Y) and 3:1 (Z) weight
ratios of Emix (Km) at ambient
temperature. The one-phase
region is designated by 1U and
the multiphase region by MU.
The dilution line (a, b) at oil/
Emix of 0.25 represents the
investigated systems’
compositions (I1 to I6)
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from an oil-rich region (i.e., w/o ME) to a water-rich region
(i.e., o/w ME), the transition between these two regions
passes through a bicontinuous isotropic region (Fanun
2008). The area of ME isotropic region changed slightly in
size with Km in the order of: 3:1[ 2:1[ 1:1. The phase
study revealed that the maximum solubilization of water
was achieved in ME systems when Km was 3:1 and so it
was fixed at 3:1 for further studies.
The maximum percentage of water in the phase diagram
with IPM as an oil phase (Fig. 1z) was 86.94 % w/w for the
ratio of oil to Emix of 0.11 with the content of Emix at Km
= 3:1 of 9.89 % w/w and 76 % w/w for ratio of oil to Emix
of 0.25 with content of Emix at Km = 3:1 of 20 % w/w.
The obtained results suggested that the maximum solubi-
lization of water (Wmax) was increased with decrease in the
amphiphile content in the ratio of oil to Emix in the order of
0.11[ 0.25[ 0.42[ 0.6[ 1[ 1.5[ 2.3[ 9. The Wmax
was achieved at a ratio of oil to Emix less than 0.25. IPM
was solubilized completely with LAB and theWmax of IPM/
LAB mixture was found to be higher. It was considered that
IPM, due to its preferable chemical structure, probably
penetrated the interfacial layer and interacted with LAB,
increasing its efficiency in solubilizing water. Hence, the
obtained results indicated that LAB showed a good effi-
ciency and water-solubilizing capacity in the presence of
IPM. These observations were quite consistent with previ-
ously reported results (Djekic and Primorac 2008).
Further six potential ME vehicles, I1–I6, for IPM as
an oil phase (Table 1) were selected at a ratio of oil to
Emix of 0.25 along the dilution line A–B in Fig. 1z. The
entire drug-loaded ME formulations containing ITTN
were prepared in the same ratios and the proportion of
ITTN was kept constant at 0.05 % w/w for all the
batches.
The average particle size of the plain MEs and drug-
loaded ME were determined. The results of particle size
analysis of ME formulation containing IPM as an oil phase
are shown in Table 1 for plain MEs and Table 2 for drug-
loaded MEs. The unloaded vehicles have a globule size in
the range of 22.4–85.9 nm, while drug-loaded vehicles
have a globule size in the range of 16.9–72.3 nm. Two
explanations, (1) undissolved drug acting as a emulsifier
and (2) reduction in emulsifier mobility, are offered in the
literature for the decrease in droplet size with the addition
of the drug due to deposition of drug particles at the in-
terface of ME (Biruss and Valenta 2008; Djekic and Pri-
morac 2008; Fanun 2008; Kantarci et al. 2007). It has been
reported that the lowest conductivity plots extend to the
largest droplet radius. The size of the droplet of unloaded
ME with low conductivity values was greater than that of
the ITTN-loaded formulation with higher conductivity
values (Patel et al. 2009, 2011b, 2013a, b, c). All the for-
mulations had droplets in the nano range, which is very
well evident from the low PDI values for both unloaded
and ITTN-loaded vehicles as described in Tables 1 and 2.
Although the PDI values of all formulations were very low,
indicating uniformity of droplet size within each formula-
tion, it was least for I6 (0.122 ± 0.012). An emulsifier can
stabilize the emulsion, not only just by forming a me-
chanical barrier, but also by producing an electrical (elec-
trostatic) barrier or surface charge. The electrical surface
charge of the droplets is produced by the ionization of
interfacial film-forming components. The surface potential
and the resulting zeta potential of emulsion droplets will
depend on the extent of ionization of emulsifiers. For MEs
with non-ionic emulsifier, the zeta potential can be used to
analyze the charge of the system (Biruss and Valenta
2008). The zeta potential of plain and ITTN-loaded ME
formulations are presented in Tables 1 and 2, respectively.
The zeta potential values of all the formulations are less
than -30 mv. It can be seen that the ME system is
negatively charged and on addition of ITTN, the zeta po-
tential values in the ME did not change significantly (Patel
et al. 2013a, b, c). The % T values of plain and ITTN-
loaded ME formulations were between 98 and 100 %
(Tables 1 and 2). Hence, all the plain and medicated ME
formulations were found to be optically clear. The TEM
imaging of ITTN-loaded ME formulation is shown in
















IPM LAB PO Water
I1 18 54 18 10 85.9 ± 3.7 0.261 ± 0.021 -27.86 ± 2.32 98.04 ± 0.75 6.30 ± 0.01 2.4 ± 0.1 120 ± 0.05
I2 16 48 16 20 82.7 ± 1.8 0.159 ± 0.058 -31.55 ± 1.62 98.26 ± 0.66 6.49 ± 0.05 6.7 ± 0.2 112 ± 0.06
I3 14 42 14 30 70.1 ± 1.7 0.321 ± 0.026 -33.67 ± 2.10 98.05 ± 0.65 6.50 ± 0.04 13.8 ± 0.6 92 ± 0.03
I4 12 36 12 40 50.1 ± 1.2 0.278 ± 0.014 -32.18 ± 1.89 98.47 ± 0.62 6.62 ± 0.03 29.5 ± 0.3 75 ± 0.08
I5 10 30 10 50 34.9 ± 1.2 0.198 ± 0.025 -38.76 ± 2.41 98.97 ± 0.56 6.28 ± 0.02 50.8 ± 0.5 80 ± 0.02
I6 08 24 08 60 22.4 ± 0.2 0.127 ± 0.015 -37.98 ± 2.05 99.17 ± 0.67 6.67 ± 0.06 68.6 ± 0.4 38 ± 0.07
a Mean ± SEM, n = 3
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Fig. 2. The TEM images revealed that the particle size was
in the nanometric range and that particle had nearly
spherical morphology without aggregation which is in ac-
cordance with particle size analysis. Figure 3 shows the
particle size distribution by intensity of optimized ITTN-
loaded ME formulation. The ITTN content of ME formu-
lations was found to be in the range of 99.12–99.98 % w/w
of the theoretical value (0.05 % w/w) (Table 2). The
samples were examined by ocular inspection in a cross
polarizer for sample homogeneity and birefringence. All
ME formulations appeared completely dark when observed
under cross polarizer which confirmed its optically
isotropic nature (Draize et al. 1944; Shah et al. 2007). The
rate of diffusion of a drug is dependent on the pH of the
formulation. It is one of the factors influencing skin
penetration (Patel et al. 2013a, b, c). The pH values for ME
formulations were found in the range of 6.28–6.67
(Table 1). The incorporated ITTN did not affect the optical
texture of the ME formulations and did not influence the
pH values of the ME formulations significantly (Table 2).
Electrical conductivity is a structure-sensitive property and
there are some studies reported on the systems of non-ionic
emulsifiers. Although reported in literature, the conduc-
tivity measurement were done without incorporating a
small amount of aqueous electrolyte (NaCl) responsible for
charge transport due to its effect on phase behavior and
structural properties of MEs, resulting in phase separation.
The investigated ME formulations containing non-ionic
amphiphiles exhibited electroconductive behavior, in spite
of its non-ionic nature. Figure 4a displays the influence of
water volume fraction (Uw, % w/w) change on the elec-
trical conductivity (r, lS/cm) of ME formulations. Along
with the increase in water content, the values of electrical
conductivity increased continuously. The low conductivity











































































































































































































































































































































































































































































































































































































































































Fig. 2 The TEM image of isotretinoin-loaded microemulsion
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suggest that the system undergoes a structural inversion
from w/o to o/w MEs. These changes have been attributed
to the occurrence of a percolation transition. In the per-
colation threshold model, the conductivity remains low up
to a certain critical volume fraction of water (Uc) as the
w/o droplets surrounded by continuous oil phase are iso-
lated from each other, thus contributing very little to
electrical conductance. When the volume fraction of water
reaches the percolation threshold (Uc = Up), clusters of
some conductive droplets which begin to contact each
other are formed. Beyond Up the conductivity increases
sharply and rapidly as the number of clusters increases.
This has been attributed to the formation of water cylinders
or channels in an oil phase due to the sticky collisions
through transient merging of spherical microdroplets of
water phase in the w/o ME (Fanun 2008). As shown in
Fig. 4a, the electrical conductivity of the oily mixtures
containing IPM was almost zero as long as Uw was smaller
than the critical volume fraction (Uc) 10 % w/w. However
when the water content was raised above Uc = 10 % w/w,
the value of conductivity increases fast up to
Uw = 50 % w/w. This phenomenon is known as percola-
tion and the critical Uw at which it occurs is known as
percolation threshold (Up = 10 % w/w). At
Uw[ 50 % w/w, it increases continuously, but with
relatively moderate rate up to a maximum Uw = 60 %
w/w. This shows that the conductivity of the system was
not significantly affected by further addition of water. After
reaching the maximum value, the conductivity of the sys-
tem was slightly decreased by further addition of the water
phase. This suggested the further dilution of o/w ME with
the added water which decreased the concentration of the
dispersed oil droplets. Thus, the r–Uw curve illustrates the
occurrence of the three structural regions: w/o
(Uw\ 10 % w/w), non-spherical w/o-bicontinuous-non-
spherical o/w (10 % w/w\Uw\ 50 % w/w) and o/w
(Uw[ 50 % w/w). The conductivity results obtained for
plain and ITTN-loaded ME formulations (Tables 1 and 2)
showed that loading ITTN and the addition of water phase
into the formulations had no negative effects on system
stability. When an unstable emulsion system and phase
separation occurs, the conductivity values are greatly re-
duced (Kantarci et al. 2007). However, the conductivity
values for unloaded vehicles were about two to three fac-
tors lower than those of ITTN-loaded formulations. The
variation of viscosity as a function of water content along
the dilution line (A–B) for the system IPM/LAB/PO/water
(Fig. 1) is presented in Fig. 4b. All the tested samples were
liquids of low viscosity. Three regions were observed in
this curve. In the first region, where the water volume
Fig. 3 The particle size
distribution by intensity of
optimized isotretinoin-loaded
microemulsion
Fig. 4 a Electrical conductivity
(r) and b viscosity (g) as a
function of water phase volume
fraction (Uw) in the system with
oil/Emix 0.25 and Km 3:1 for
microemulsion formulations
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content is below 10 % w/w, the viscosity increases. Then a
sharp decrease is observed at water volume fractions above
10 % w/w. For water contents between 10 and 40 % w/w,
the viscosity of the ME systems decreases slowly. A slight
increase in viscosity is also observed with increase in the
water volume fraction from 40 to 55 % w/w. A sudden
decrease in the viscosity is observed with increase in the
water volume fraction above 55 % w/w. The viscosity is
sensitive to interactions and it is rather an interesting
technique to study interactions in systems of known
structure. The change in viscosity with the increase in
water volume fractions should be correlated to structural
effects due to interfacial packing (Biruss and Valenta 2008;
Fanun 2008; Kantarci et al. 2007). For water content below
10 % w/w, the increase in viscosity indicates increase of
volume fraction of dispersed phaseand reflects a transfor-
mation of system microstructure due to growth of spherical
droplets into larger non-spherical droplets by an attractive
interaction as a function of Uw. The position of the max-
imum on the g-Uw curve is at water phase of about 10 %
w/w. The reduction in the viscosity with the increase in
water content above 10 % w/w to about 60 % w/w seems
to be attributed to the fact that the emulsifiers move from
the bulk to the interface to cover the water and oil in a
bicontinuous structure. The small increase in the dynamic
viscosity for water contents above 40 % w/w suggests a
structural transformation from a bicontinuous structure to
oil in water structure. This phenomenon can also be ex-
plained in terms of a decrease in the hydrophobic interac-
tion of the emulsifier tails. High water contents cause a
reduction in the inter-droplet interactions and reduction in
the viscosity. The relatively low viscosity values indicate
that the MEs formulated are composed of individual
spherical droplets or bicontinuous structures and no ani-
sometric aggregates are present (Patel et al. 2011b). The
results of viscosity measurements for plain and ITTN-
loaded ME formulations (Tables 1 and 2) indicate that the
viscosity values of the ITTN-loaded MEs were higher than
the unloaded vehicles. The conductivity and viscosity data
confirmed the continuous structural transitions during the
increase of water phase volume fraction in the selected oil/
emulsifier/co-emulsifier mixture.
In vitro skin permeation studies were conducted to
measure the rate and extent of compound transport across
the skin. Figure 5(A) shows the release profiles of ITTN
from the ME formulations. The cumulative amount of
ITTN that had permeated through rat skin (lg/cm2) was
plotted as a function of time (hours). It is possible to cal-
culate the steady-state flux (Jss) obtained from the slope of
the linear portion (2–8 h) of the graph (Bachhav and Pa-
travale 2009; Djordjevic 2004; Patel et al. 2009, 2011b;
Shah et al. 2007). The permeation parameters of the tested
ME formulations are presented in Table 3.
A steady increase of ITTN in the receptor chamber with
time was observed. The permeation profiles of MEs fol-
lowed zero-order kinetics. The depletion of ITTN in the
external phase because of the permeation into the skin can
be supplemented by the release of the ITTN from the in-
ternal phase. Thus, the zero-order release kinetics and
sustained and controlled delivery of ITTN were obtained
(Bachhav and Patravale 2009; Djordjevic 2004; Patel et al.
2009, 2011b, 2013a).
When all the formulations containing IPM as an oil
phase were evaluated according to the release rate of ITTN,
I6 showed the highest flux value (0.0380 ± 0.0057 lg/cm
2/
h) and I1 showed the lowest flux value (0.0318 ± 0.0021
lg/cm2/h). However, there was no significant difference
Fig. 5 In vitro permeation
profiles of isotretinoin through
rat skin from a microemulsion
formulations, b marketed gel
and microemulsion-based gel
(ITTN-MBG) (mean ± SEM,
n = 3)
Table 3 The permeation parameters of isotretinoin-loaded mi-




I 0.0318 ± 0.0021 6.36 9 10-5 ± 0.10 9 10-6
I2 0.0320 ± 0.0013 6.40 9 10
-5 ± 0.08 9 10-6
I3 0.0340 ± 0.0034 6.80 9 10
-5 ± 0.12 9 10-6
I4 0.0355 ± 0.0045 7.10 9 10
-5 ± 0.16 9 10-6
I5 0.0368 ± 0.0029 7.36 9 10
-5 ± 0.14 9 10-6
I6 0.0380 ± 0.0057 7.60 9 10
-5 ± 0.18 9 10-6
Mean ± SEM, n = 3
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between flux values of all the formulations. From Table 3,
it can be concluded that the permeation rate of ITTN in-
creases with decrease in the concentration of oil and Emix
and increase in the concentration of water (Bachhav and
Patravale 2009; Djordjevic 2004; Patel et al. 2009, 2011b,
2013a).
Due to low viscosity of MEs, the mobility of drugs in
MEs is more facile and this is important for the permeation
into skin. So the water content of ME formulations was
varied between 10 and 60 %, as there exists a really tight
relationship between the hydration effect on the stratum
corneum and dermal permeation (Biruss and Valenta 2008;
Fanun 2008; Kantarci et al. 2007).
It was concluded that the content of Emix in ME af-
fected the skin permeation rate of ITTN significantly. As
the content of Emix was decreased from 72 to 32 % w/w,
the skin permeation rate of ITTN was also increased. This
may be due to increased thermodynamic activity of the
drug in the ME at the lower content of Emix, as ITTN is
soluble in Emix. To evaluate the effect of oil phase on the
permeation rates, different MEs containing IPM concen-
tration from 8–18 % w/w were compared. The ME I6
(containing 8 % w/w oil phase) showed the highest per-
meation rates. The increase in oil phase in the vehicles
resulted in decrease of permeation rate. It is considered that
a high content of Emix in the MEs (I1, I2, I3, I4, and I5) may
make the effect of oil on the skin permeation less pro-
nounced. Also, the high solubility of drug in the oil phase
could lead to an unfavorable partition from the oil phase
(Patel et al. 2009, 2011b, 2013a, b, c). Thus, it was con-
cluded that the high permeation of MEs may be attributed
to the combined effects of both the lipophilic and hy-
drophilic domains of MEs. Large microparticles ([10–20
lm) do not penetrate the skin and remain on the stratum
corneum, but particles of\3 lm are randomly distributed
in the stratum corneum and penetrate the skin (Shah et al.
2007) When the particle size is very small, the number of
vesicles that can interact on a fixed area of stratum cor-
neum may be increased, thereby increasing its efficiency in
the percutaneous uptake of drugs. The lower permeation of
ITTN from ME containing larger size particles as com-
pared to ME with smaller particles may be explained by the
above-mentioned facts (Fanun 2008).
ME showed good shelf stability and no phase separation,
cloudiness or any flocculation or precipitation for
6 months. These samples also showed no sign of phase
separation under stress when subjected to centrifugation at
50009g for 30 min. Thus centrifuge tests showed that all
MEs had good physical stability. All physicochemical pa-
rameters were determined at weekly intervals for the first
month and monthly interval for the subsequent months.
However, no significant change in the physicochemical
parameters was observed (data not shown).
Development and evaluation of microemulsion-
based gel
The formulation I6 (containing 8 % w/w IPM, 32 % w/w
Emix, 60 % w/w water) having appropriate physicochem-
ical parameters and higher permeation parameters was
considered as the optimized formulation. The MBG of the
optimized formulation was developed using a suitable
polymer capable of modifying the rheological behaviour.
Various gelling agents, namely hydroxypropyl methylcel-
lulose (Methocel K4 M) and non-benzene grade Carbopol
polymers (Carbopol 971P NF, Carbopol 974P NF and
Carbopol 980P NF) were evaluated for their ability to gel
optimized ITTN-ME. Also, different concentrations of the
above-mentioned gelling agents were tried. The suitable
gelling agent was selected on the basis of compatibility
with ME structure, feel and ease of spreadability. When
hydroxypropyl methylcellulose (Methocel K4 M) and
Carbopol 974P NF were added to ME to prepare MBG,
only an ivory-white gel was obtained indicating that the
structure was disturbed. So it was concluded that they were
not a suitable gel matrix for this ME system. The incor-
poration of Carbopol 980P NF and Carbopol 971P NF
into ME could increase the viscosity and also maintain the
ME structure. Further, since MBG containing Carbopol
971P NF had the most appropriate fluidity and spread-
ability for topical administration, it was selected as an
optimum gel matrix for optimized ME (Bachhav and Pa-
travale 2009).
Briefly, the MBG of I6 was prepared as shown in
Table 4. The influence of the method of addition of Car-
bopol 971P NF on the formation of MBG was investi-
gated. Carbopol 971P NF was directly added into ME or
the aqueous phase of ME, respectively (Bachhav and Pa-
travale 2009).
As per the above observations, it can be concluded that
the gel network increased the viscosity of the system, with
no influence on the spontaneous dispersion of oily phase in
aqueous phase or the spontaneous formation of ME. The
order of addition of Carbopol 971P NF had no significant
influence on the formation of MBG, but might influence the
homogenized swelling of Carbopol 971P NF. In a
Table 4 Composition of microemulsion-based gel containing
isotretinoin
Components Content
Isotretinoin (% w/w) 0.05
Carbopol 971P NF (% w/w) 2
Isopropyl myristate (% w/w) 8
Labrasol (% w/w) 24
Plurol oleique (% w/w) 8
Water (g) Quantity sufficient to produce 100 g of gel
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subsequent study, MBG was prepared by mixing the
swollen gel matrix with the oily phase.
Further, the influence of the different concentrations of
Carbopol 971P NF on the viscosity of ME was evaluated.
0.5, 1.0, 1.5 and 2 % w/w Carbopol 971P NF was swollen
in the aqueous phase. After TEA was used to adjust pH of
the swollen gel matrices, MBG was prepared by mixing the
oily phase with various gel matrices. The incorporation of
Carbopol 971P NF into ME resulted in a significant in-
crease of viscosity. The viscosity of MBG containing 0.5,
1.0, 1.5 and 2 % w/w Carbopol 971P NF was 0.7 9 103
cp, 1.8 9 103 cp, 3.1 9 103 cp and 6.5 9 103 cp, respec-
tively. MBG containing 0.5 % Carbopol 971P NF had a
relatively high fluidity. However, 2 % w/w Carbopol
971P NF resulted in the most appropriate fluidity for
topical administration. So, 2 % w/w Carbopol 971P NF as
the optimum gel matrix was added to ME I6 to obtain MBG
containing ITTN.
The ITTN content of MBG was found to be
98.97 ± 0.053 % w/w of the theoretical value (0.05 %
w/w). The pH of the gel was 6.2 ± 0.03 which is in the
physiological range. Rheology is less precise, but a simpler
way to identify anisotropic aggregates in the system. In
ME, the formation of liquid crystalline stage coincides with
the formation of nonspherical aggregates (cylindrical or
lamellar aggregates), which obstructs the flow in the dis-
persion medium. This produces high yield value (Biruss
and Valenta 2008; Djekic and Primorac 2008; Fanun 2008;
Kantarci et al. 2007). MEs being isotropic (spherical)
systems offer less resistance to flow and exhibit low vis-
cosity as compared to macroemulsions. The rheological
properties (study of deformation and flow of matter) are
vital in various pharmaceutical areas. It helps to monitor
the effect of vehicles consistency on release of drug from
the preparations and subsequent percutaneous absorption.
It is also important from the manufacturing point of view.
For a pharmaceutical or cosmetic product to be spread
easily on the skin without running, it must be neither too
fluid nor too viscous and show plastic or pseudoplastic
rheological behavior (Bachhav and Patravale 2009;
Kantarci et al. 2007). The ITTN-MBG showed pseudo-
plastic behavior which facilitates the flow and improves the
spreading characteristics of the formulation, and the vis-
cosity of MBG at 5 rpm was found to be
6.5 9 103 ± 0.2 9 103 cp.
Gel spreadability is an important parameter. Application
of the formulation on the inflamed part would be more
comfortable if the base spreads easily, exhibiting maximum
slip and drag. When a weighed quantity of gel was placed
in between two glass plates of known weight, it spread
uniformly to produce a circle, the diameter of which was
related to its spreadability; the larger the diameter, the
better was the spreadability (Bachhav and Patravale 2009;
Kantarci et al. 2007). The diameter of MBG was found to
be 7.2 ± 0.01 cm, while the diameter of the marketed gel
was found to be 5.8 ± 0.02 cm indicating that the
spreadability of MBG was better than that of conventional
gel. This might be because of the loose gel matrix nature of
MBG formulation due to the presence of oil globules rather
than the conventional gel matrix.
MBG was found to be stable at room temperature for
6 months with no significant change in the viscosity
(6.7 9 103 ± 0.8 9 103 cp), spreadability
(7.0 ± 0.01 cm), pH (6.4 ± 0.05) and drug content
(98.87 ± 0.043 % w/w). The centrifuge tests indicated that
it had good physical stability.
To assess the skin retention and penetration of ITTN
from MBG, the in vitro permeation ability through skins
and into skins were assessed using Franz diffusion cells.
The in vitro permeation of ITTN through rat skin from
MBG and marketed gel (Sotret) was calculated in terms
of mean cumulative amount diffused at each sampling
time point during a time period of 12 h (Fig. 5b). The
permeation parameters of MBG and marketed gel are
presented in Table 5. To understand the mechanism of
drug release from these formulations, the data were
treated according to zero-order (cumulative amount of
drug released vs time), first order (log of the cumulative
amount of drug released v/s time) and higuchi (cumulative
amount of drug released v/s square root of time) equation.
Moreover the plot of cumulative amount of drug released
vs time showed a linear relationship (r2 = 0.9875) in case
of ITTN-MBG, thus indicating that ITTN permeation
followed zero-order kinetics (Table 5). In the case of
marketed gel the plot of cumulative amount of drug re-
leased vs square root of time showed a linear relationship
(r2 = 0.9806), indicating that ITTN permeation followed
Higuchi model (Table 5).
Although the authors did not attempt to establish the
mechanism of ITTN permeation through skin from
MBG, we believe that the static droplets could come in
close contact with the skin due to adhesiveness of the
polymer and a large amount of inner IPM might pene-
trate into the stratum corneum due to the small diameter
of droplets. This phenomenon has been hypothesized in
some investigations (Biruss and Valenta 2008; Kantarci
et al. 2007; Escribano et al. 2005). Though the flux
value of ITTN-based gel (0.0265 ± 0.0017 lg/cm2/h) is
lesser than marketed ITTN gel (0.0284 ± 0.0047 lg/cm2/
h), the difference is not significant (P[ 0.05). Thus it
was hypothesized that MBG may avoid the systemic
uptake of ITTN in comparison to marketed gel and
might present a potential to avoid systemic adverse side
effect.
Also, the flux value of MBG of I6 (0.0265 ± 0.0017 lg/
cm2/h) was found to be less than ME of I6
Appl Nanosci (2016) 6:539–553 549
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(0.0380 ± 0.0057 lg/cm2/h) (P\ 0.05). In literature, it
has been reported that the release of drug from viscosized
ME was higher than that from fluid ME. But our results
were not in accordance with previously published studies
(31, 32). This might be attributed to gel formation in ME,
by the addition of Carbopol 971P NF that will increase its
viscosity, transform the microstructure of ME to lamellar
or a highly ordered microstructure and further decrease the
permeation in the skin (Huang et al. 2008).
Infrared study
The infrared spectra of ITTN pure powder, plain ME, IME
and MBG are as shown in the Fig. 6a–d. ITTN was char-
acterized by bands around 1700–1500 and
1300–1100 cm-1 that correspond to C = O and C–O
stretching vibrations. The IR spectrum of ITTN-ME and
ITTN-MBG is entirely different from ITTN, while it
closely resembles the spectrum of unloaded ME. The
characteristic bands of ITTN either disappeared or few
bands of ITTN were present with reduced intensity prob-
ably due to the restriction inside the formulation matrix.
The absorption band at 3400 cm-1 due to hydroxyl
stretching was not affected in ITTN-ME and ITTN-MBG,
which emphasized the absence of any possible interaction
between the drug and the formulation components used
(Patel et al. 2013c).
Skin retention study
The accumulative amounts of ITTN in skin from MBG and
marketed gel were 3.53 ± 0.07 lg and 3.02 ± 0.04 lg,
respectively. MBG could significantly (P\ 0.05) increase
the accumulative uptake of ITTN in skin compared to the
marketed formulation. This result supported our hypothesis
made in skin permeation studies on rat skin. The more
ITTN permeates, the less is it retained in the skin and might
lead to systemic adverse side effects (Liu et al. 2007). ME
has been shown to improve the dermal localization of
several topical therapeutic agents. This was one of the
reasons for employing the ME approach for topical deliv-
ery of ITTN, as its epidermal localization is highly desir-
able for enhancing the treatment of skin diseases such as
psoriasis, acne, photoaging and epithelial skin cancer (Liu
et al. 2007).
Histopathological investigation
The histology of excised rat skin in the control and that
treated with optimized ME, MBG and marketed gel is
Table 5 The permeation and modeling parameters of isotretinoin from marketed gel and microemulsion-based gel (ITTN-MBG)
Formulation Jss
a (lg/cm2/h) Kp
a (cm/h) Modeling parameters (R2)
Zero Order (R2) First Order (R2) Higuchi (R2)
Marketed gel 0.0284 ± 0.0047 5.68 9 10-5 ± 0.07 9 10-6 0.9721 0.9722 0.9806
ITTN-MBG 0.0265 ± 0.0017 5.30 9 10-5 ± 0.05 9 10-6 0.9875 0.9768 0.9751
a Mean ± SEM, n = 3
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shown in Fig. 7a–d. The microscopic observations indicate
that the optimized ME (ITTN-ME), MBG (ITTN-MBG)
and marketed gel had no significant effect on the micro-
scopic structure of the skin. The surface epithelium lining
and the granular cellular structure of the skin were totally
intact. No major changes in the ultrastructure of skin
morphology could be seen and the epithelial cells appeared
mostly unchanged (Patel et al. 2009, 2011b, 2013a, b, c).
Skin irritation testing
Skin irritation limits the utility and acceptability of ITTN
therapy by patients. Most of the currently marketed con-
ventional dosage forms are not able to reduce the irritation
caused by topical application of ITTN. Hence, we aimed to
formulate a delivery system of ITTN which was able to
reduce erythema (skin irritation). It was hypothesized that
encapsulation of ITTN in ME would reduce the contact of
the acidic function (–COOH) of ITTN (the triggering factor
for erythematic events) with the stratum corneum, thus
resulting in reduced erythematic episodes (Draize et al.
1944). The results obtained from the primary skin irritation
studies are listed in Table 6 and the actual photographs are
depicted in Fig. 8a–d. Draize patch test is a reliable method
and the results obtained from this study can be linked to
those obtained in humans (Biruss and Valenta 2008;
Kantarci et al. 2007; Escribano et al. 2005). The skin ir-
ritation studies indicated that MBG containing ITTN re-
sulted in less irritation as compared to marketed ITTN
formulation (Sotret gel) after 72 h of application
(Table 6). Thus, MBG demonstrated advantage over mar-
keted formulation in improving the skin tolerability of
ITTN, indicating their potential in improving patient ac-
ceptance and topical delivery of TTN.
Conclusion
Collectively, the results demonstrate that MBG may be a
more promising approach for the topical delivery of ITTN.
It is assumed that MBG due to its appropriate physico-
chemical properties, high skin permeation ability, higher
accumulative uptake in skin and improved skin tolerability
may be more suitable for targeted therapy, which could be
developed as a novel regime for topical administration of
ITTN. Nevertheless, significant work is yet to be conducted
to elucidate the possible mechanism(s) of drug delivery
Fig. 7 Light microscopic
photographs of in vitro
histological study. a Control.
b The rat skin treated with
optimized microemulsion
(ITTN-ME). c The rat skin
treated with marketed gel. d The
rat skin treated with
microemulsion-based gel
(ITTN-MBG)
Table 6 Mean erythema scores for various isotretinoin formulations
obtained at the end of 24, 48 and 72 h
Formulations Erythyma score
(total)
24 h 48 h 72 h
Control (Group 1) 0 0 0
Marketed gel (Group 2) 1 2 2
Microemulsion-based gel without isotretinoin
(Group 3)
0 0 0
Microemulsion-based gel containing isotretinoin
(Group 4)
0 0 1
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into the skin. Clinical investigations with emphasis on the
desired therapeutic efficacy and favorable safety profile
followed by pilot-scale studies on manufacturing the pro-
duct for commercial use also need to be considered.
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